Serum Institute’s Adar Poonawalla warns against return to business-as-usual approach

Serum Institute’s Adar Poonawalla warns against return to business-as-usual approach

Serum Institute of India CEO Adar Poonawalla on Friday warned against the return to the business-as-usual approach, saying we “can’t afford to put a price tag on the life of a citizen” as the pandemic is not behind us yet. The chief executive defended his call for lowering the vaccination gap to six months from … Read more

Covid-19: Covovax better booster for people vaccinated with Covishield, virologist says

Covid Vaccine 03 2

Jameel, the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia, said there is no data for the other combinations of vaccines as of now. Of the vaccines against COVID-19 approved in India, Covovax would be a better booster for those who were administered Covishield jabs than another dose of the same … Read more

COVID-19: CDSCO panel recommends emergency-use authorisation for Serum Institute’s Covovax vaccine

Adar Poonawalla Reuters

On November 27, the Subject Expert Committee on COVID-19 had evaluated and deliberated on SII’s application and sought additional data from the company. An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India’s COVID-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash … Read more

Covid-19 vaccine update: What we know about Covovax and Serum Institute’s bridging study

Covid vaccine2 1

For Covovax, SII will be testing the safety by using 1,600 participants in 19 sites. Recently, Adar Poonawalla, CEO of Serum Institute of India (SII) said that the company will soon be working on the bridging study of Covovax vaccine and stockpiling its doses from April this year. It is to note that Covovax is … Read more